Morgan Stanley analyst Ioannis Masvoulas lowered the firm’s price target on Aperam to EUR 31 from EUR 35 and keeps an Equal Weight rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks